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ABSTRACT
state of hyperglycemia which usually accompanied by increasing blood glucose level. The combination of Phyllanthus 
niruri herbs and Zingiber americans rhizome has been produced as herbal medicine for the treatment of diabetes. The 
activity of herbal medicine product containing P. niruri and Z. americans in vivo. Antidiabetes activity was tested using 
oral glucose tolerance and alloxan induced methods. The blood glucose levels were measured in each experiment. In 
addition, the plasma triglyceride and total cholesterol levels were also measured. The results showed that the decrease 
of blood glucose levels on oral glucose tolerance method were 40.98, 44.84, and 47.02% at doses of 90, 135, and 203 
mg/kg BW, respectively (p <0.05) compared to control. While the decrease in blood glucose levels in alloxan induced 
method were 33.05, 38.82, and 41.79% at dose 90, 135, and 203 mg/kg BW, respectively (p <0.05) compared to control. 
The extract of dose 203 mg/kg BW appeared to be the most potent to decrease blood glucose levels in both methods, 
but did not show suppression activity of triglycerides and total cholesterol plasma. Suppression activities of serum 
triglycerides and total cholesterol were shown after treatment with the extract dose 90 and 135 mg/kg BW, which were 
each were 0.15, 0.16, and 1.85% w/w, respectively.
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ABSTRAK
keadaan 
hiperglikemik yang diikuti dengan tingginya kadar gula dalam darah. Kombinasi tanaman herba Phyllanthud niruri 
dan Zingiber americans telah dijadikan sebagai produk ubat herba untuk mengubati penyakit diabetes. Kesan daripada 
gabungan dua tanaman ini masih berdasarkan kepada data empirik. Kajian ini dijalankan untuk membuktikan 
khasiat anti-diabetes daripada salah satu produk ubatan herba yang mengandungi P. niruri dan Z. americans secara 
in vivo. Kajian ke atas anti-diabetes ini dijalankan menggunakan kaedah induksi aloksan. Kandungan gula dalam 
darah untuk setiap percubaan dihitung. Selain itu, kadar trigliserids dan kolestrol juga diukur. Hasil menunjukkan 
bahawa kadar gula dalam darah dapat diturunkan dengan kaedah toleransi glukosa sebanyak 40.98, 44.84 dan 47.02% 
dengan dos 90, 135 dan 203 mg/kg BW (p < 0.05) berbanding kawalan. Penurunan dengan kaedah induksi aloksan 
pula adalah 33.05, 38.82 dan 42.79% pada dos 90, 135 dan 203 mg/kg BW (p < 0.05) berbanding kawalan. Ekstrak 
yang mengandungi dos 203 mg/kg BW menunjukkan penurunan kadar gula dalam darah paling tinggi dalam kedua-
dua kaedah yang digunakan, namun tidak menunjukkan aktiviti penindasan trigliserids dan jumlah plasma kolestrol. 
Aktiviti penindasan serum trigliserids dan jumlah kolesterol dilihat selepas rawatan dengan ekstrak dos 90 dan 135 
mg/kg BW
sebanyak 0.15, 0.16 dan 1.85% w/w.
Kata kunci: Jamu; kencing manis; Phyllanthus niruri; ubat herba; Zingiber americans
INTRODUCTION
Herbal medicines have been used by community to treat 
diseases and to maintain health since long ago. They 
have been developed from traditional way into modern 
processing and produced as herbal medicines by household 
into big industries. The development of herbal medicines 
product should be followed by the good quality production 
to prove the efficacy, the quality and standardization 
(Elfahmi et al. 2014). Herbal medicine produced by small 




melitus (DM) is a chronical disease with high prevalence 
in the world. In Indonesia, the diabetes patient tends to rise 
every year where in 2000, there were 8.4 million people 
with diabetes and is predicted to rise around 21.3 million 
in 2030 (Wild et al. 2004). In 2019, the diabetes patients 
reach 463 million people (IDF 2019; WHO 2019). This 
disease is defined as hyperglycaemic with abnormalities 
of carbohydrate, protein, and lipid metabolism as well as 
abnormality of production and activity of insulin (Shan 
et al. 2006). The use of antidiabetes drugs tend to increase 
since the rising of diabetes cases. Many medicinal plants 
have been reported to have antidiabetes activity. Meniran 
or Dukung anak (Phyllanthus niruri L.) belonging to 
family Phyllanthaceae is a medicinal plant that has been 
used traditionally for treat diabetes (Calixto et al. 1998; 
Nwanjo et al. 2017). Empirically, this plant has been also 
used mostly for the remedy of fever, inflammation, malaria, 
lithiasis, gonorrhea, hepatitis, genitourinary, hypertension, 
cancer, skin, digestive, hepatic, and respiratory disorders 
(Jantan et al. 2019; Sarin et al. 2014). The pharmacological 
activities of this plant were intensively studied to prove 
its traditional use. Methanol extract of this plant showed 
the highest inhibitory effect against non-alcohol-fatty liver 
disease through reduction of several parameters such as 
hepatomegaly, visceral fat weight, prevented fibrosis, 
serum total cholesterol, low-density lipoprotein, and free 
fatty acids. It also inhibited the activity of enzymes related 
to diabetes such as α-glucosidase and pancreatic lipase 
enzymes (Al Zarzour et al. 2018, 2017). The methanol 
extract was reported to have anti-inflammatory activity 
and protect the ulcer through the regeneration of mucosal 
layer and substantial prevention of the formation of 
hemorrhage and edema (Mostofa et al. 2017). While the 
aqueous extract reduced the amount of lipid peroxidation 
product, and inhibited the enzymes related to the 
oxidative stress such as superoxide dismutase, catalase, 
and glutathione peroxidase in the kidney of diabetic rats 
(Giribabu et al. 2018). P. niruri has been reported to be 
potential developed as an anticancer since it inhibits 
cancer cell in vitro (Junior et al. 2012; Tang 2013; Zheng 
et al. 2016). In addition, the pharmacological effects 
of this plant as anti-parasite, anti-bacterial, anti-virus, 
cardiovascular protective, antioxidant, anti-aging and 
skin protecting have been also reported (Nisar et al. 2018; 
Sarin et al. 2014). Only few reports have been published 
on the antidiabetes activity of P. niruri in vivo (Bavarva 
& Narasimhacharya 2007). One of them reported that P. 
niruri extract decreased the serum glucose level of type 2 
diabetes in Sprague-Dawley rats induced by streptozotocin 
(Mediani et al. 2016). Some chemical compounds from 
several secondary metabolites group have been isolated 
from this plant. It contains flavonoid group such as 
quercetin and rutin; alkaloids: allonorsecurinine, ent-
norsecurinine, and nirurine; phenolic such as gallotannins 
corilagin and geraniin. The most abundant compound 
found in P. niruri is lignin group such as phyllantin, 
hypophillantin, cubebin, nirtetarlin, and tetralin (Jantan et 
al. 2019; Nisar 2018). Two lignan compounds have been 
found in cell suspension cultures of P. niruri that has not 
been found in the original plant (Elfahmi et al. 2014). 
Lempuyang pahit (Zingiber americans Bl.) belong to 
family Zingiberaceae has been also used traditionally for 
the treatment of diabetes, stomach disease, and reducing 
blood level (Al-Amin et al. 2006; Sukari et al. 2008). The 
scientific reports on pharmacology study of this plants are 
still limited. Combination of meniran herb and lempuyang 
pahit rhizome has been produced and marketed as herbal 
medicine belong to jamu by a small enterprise for the 
treatment of diabetes. Nowadays, the evidence for the 
efficacy of this herbal medicine product is still based on 
empirical data. Therefore, there is no scientific evidence 
for the combination of two plants for the treatment of 
diabetes. The research was conducted to prove the claimed 
efficacy as antidiabetes. Antidiabes activity was studied 
using glucose tolerance and alloxan induced methods. 
In addition, the phytochemical study was also conducted 




The sample used was herbal medicine product containing 
extract of Phyllanthus niruri L. and Zingiber americans 
BI, metformin (PT. Kalbe Farma, Jakarta, Indonesia), 
alloxan monohydrate (Sigma Aldrich, Darmstaad, 
Germany), amyl alcohol, magnesium, chloroform, 
ammonia 25%, Dragendorff, and Mayer reagent, FeCl3, 
CMC-Na, Al2Cl3, sodium acetate, sodium bicarbonate, 
methanol, ethanol, toluene, and acetone (all reagent and 
solvents were analytical grades).
PHYTOCHEMICAL SCREENING AND STANDARDIZATION
Phytochemical screening was carried out to identify 
the secondary metabolites groups in the extract of 
herbal medicines product which contain P. niruri and 
Z. americans. The secondary metabolites measured 
were alkaloid, flavonoid, tannin, saponin, quinone, 
and steroid/triterpenoid. Quantitative measurement 
of total flavonoid was done by colorimetric method 
(Chang 2002). While the total phenolic compound was 
measured by Spectrophotometer UV. Several parameters 
for standardization such as total ash content, water 
content, water and ethanol extractable matter and TLC 
profile were measured according to Indonesian Herbal 
Pharmacopoea (IMH 2008). 
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ANTIDIABETES ACTIVITY USING GLUCOSE TOLERANCE 
METHOD
Male mouse Swiss Webster age 2-3 months were used as 
animal model and divided into several groups. Animals 
were fed and adapted at the lab according to standard 
procedures. Samples were prepared with dissolving of 
the extract from capsule of herbal medicines product 
with tragacanth 0.5%. Antidiabes activity was carried 
out using glucose tolerance method and alloxan induced 
method (Shan et al. 2006). For glucose tolerance method, 
mouse was fasted for 10-12 h before induction, then 
randomly divided into 5 groups consist 5 mice of each 
group. Fasting blood glucose level were measured (T0). 
Control group was given CMC Na 0.5%, standard group 
was given metformin 195 mg/kg bb, treated groups 
were given the extract with dose 90, 135, and 203 mg/kg 
BW. Thirty minutes after treatment, each group was given 
glucose solution with concentration 3 g/kg BW per oral. 
Blood glucose levels were measured at 30, 60, 90, and 
120 min after glucose treatment. 
ANTIDIABETES ACTIVITY USING ALLOXAN INDUCED 
METHOD
For alloxan induced method, mouse was fasted for 10-
12 h. Before induction, fasting blood glucose levels 
were measured so called H0. Mouse were induced with 
alloxan dose 57 mg/kg BW i.v. On day 7 after induction 
(H7), blood glucose levels were measured. Samples were 
given to mouse with the blood glucose level higher than 
225 mg/dL. Diabetic mouse was randomly divided into 
five groups. Control group was given CMC-Na 0.5%. 
Standard group was given metformin 195 mg/kg BW. 
Three treated groups were given extract sample with three 
different concentrations which were 90, 135, and 203 mg/
kg BW, respectively. Prior to treatment, samples were 
suspended in CMC-Na 0.5% solution. The treatment was 
done during 21 days. Blood glucose levels of all mouse 
groups were measured on day 8, 10, 14, 21 and 28 using 
glucose strip test and glucometer GlucoDr™. Data were 
statistically analyzed using ANOVA method.
CHOLESTEROL AND TRIGLYCERIDE ANALYSIS
In addition, total cholesterol and triglyceride levels were 
measured before induction (H0), and after induction 
(H7). Cholesterol total was measured using enzymatic 
colorimeter method. Three type of samples were 
prepared, which were blank, standard, and treated solution. 
Blank solution consists of total cholesterol reagent. 
Standard solution consists of 1 mL of reagent and 10 µL 
of standard solution. Treated samples consist of 1 mL 
reagent and 10 µL of tested animal serum. All solution 
was incubated at room temperature (18-30 °C). Absorbance 
of all solutions were measured at wavelength of 546 
nm. Total triglyceride levels were measured using GPO 
enzymatic colorimeter method. Three types of solution 
as mentioned with different reagent were prepared, 
followed by the same procedure with determination of 
total cholesterol level. 
RESULTS AND DISCUSSION
The herbal product which contains P. niruri and Z. 
americans produced by small enterprise was registered 
in Indonesian FDA. This herbal medicine product was 
classified as jamu or traditional medicine since the efficacy 
claim is based on empirical data. There is no scientific 
study to prove the claim yet. Through the community 
services supported by Indonesian Ministry of Higher 
Education and with collaboration with the producer, the 
in vivo antidiabtes study of the product was carried out. 
Phytochemical study and quantitative measurement of the 
extract sample, showed that the product contain flavonoid, 
phenol, and tannin, with total of each were 0.15, 0.16, and 
TABLE 1. Standardization parameter of extract sample was compared to the standard according to 
Indonesian herbal pharmacopoeia (FHI)
Parameter Extract (%)
Phyllanthus niruri extract 
(FHI in%)
Water content 3.98* < 17
Total ash content 1.04 < 3.5
Lost on drying 6.15 -
Water extractable matter 67.58 -
Ethanol extractable matter 6.69 -
Total flavonoid 0.15 3.2
Total phenol content 0.16 -
Total tannin content 1.85 -
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1.85% w/w, respectively. For standardization process, 
some parameters are shown in Table 1, indicated that the 
extract sample fulfilled the standard of Indonesia herbal 
pharmacopoeia for water and ash contents, however, the 
flavonoid total was below standard. Others parameter 
were not included in FHI for extract monograph, they are 
included in the crude dried plant material. These parameters 
indicated the quality of extract (IMH 2008). 
Further analysis of chemical components of extract 
sample using thin layer chromatography (TLC) showed 
the chromatogram profile as Figure 1. Almost all bands 
showed by the P. niruri and Z. americans were exist in 
the extract sample. At least 5 of 9 bands which was shown 
in extract samples have similar Rf value as shown by P. 
niruri extract. While 4 other bands of sample extract have 
similar Rf value as shown by Z. officinale extract. These 
results confirmed that the herbal medicine product contains 
these two plant extracts. In addition, after visualization 
using citroborate, a specific spray reagent for flavonoid, 
also confirmed the standard of extract sample. One of the 
bands was a quercetin compound.
Antidiabes test using glucose tolerance method was 
done for normal male mouse with blood glucose level 
ranging 96-107 mg/dL. The value complies with the 
value of normal value published before which is below 
199 mg/dL (Fajardo et al. 2014). The study was carried 
out to determine whether the extract sample inhibit the 
increase of blood glucose level and recover it into normal 
after the increase caused by glucose induction. The blood 
glucose level increased for all animal groups, 30 min 
after glucose intake (T60), The treated groups showed 
the lower increase of blood glucose level compared to 
control group. After T60, the reducing of blood glucose 
level was significant. Sixty minutes after treatment (T90), 
there was significant different of blood glucose level for 
control, the samples of dose 90, 135, and 203 mg/kgBW 
compared to T60 (Figure 2). Measurement after T60, each 
treated group showed the reducing of blood glucose level 
and significantly different to control group (p<0.05). 
Metformin as a standard showed the highest reducing of 
glucose blood level. Metformin reduced the blood glucose 
level with the mechanism to increase the insulin sensitivity 
in liver and peripheral tissue. It reduces the production 
of glucose by liver and increase the glucose intake by 
peripheral tissue (AHFS 2008). The different of reducing 
level in T60-T120 and T60-T150 for treated groups is not 
significant to standard metformin group. The reducing of 
blood glucose levels after 120 min treatment with dose 90, 
135, and 203 mg/kg BW were 40.98, 44.84, and 47.02%, 
respectively. The group treated with dose 203 mg/kg BW 
gave the reducing level similar to standard metformin and 
appear as the dose with highest level of reducing (Figure 
3). It assumed that the sample was not only able to suppress 
the increase of blood glucose level, but also to reduce it. 
For alloxan induced method, mouse was induced 
using alloxan monohydrate. Alloxan was given with dose 
57 mg/kg BW i.v. Alloxan has the diabetogenic effect to 
β-pancreas cell through some mechanism such as inhibition 
of glucokinase activity, production of free radical and 
disturb the homeostasis of intracellular calcium ion 
(Szkudelski 2001). The time needed to provide diabetic 
animal with stable blood glucose level above 225 mg/
dL was normally reached after 3-7 days. On day 7 after 
induction, blood glucose level of mouse was ranging 312-
455 mg/dL. This range was big enough, since the alloxan 
effect is influenced by nutrition status and age of animal 
model (Szkudelski 2001). Diabetic animal model for this 
study was moderate-high model. Diabetic condition was 
provided due to the alloxan activity toward β-pancreas 
caused insulin deficiency. Profile of glucose level for day 
7-28 is similar between standard and treated groups. Day 
14, standard and treated groups with dose 203 mg/kg BB 
showed the statistically significant different (p<0.05) on 
blood glucose level compared to day 7. While other 
treated group dose (90 and 135 mg/kg BW) showed the 
different blood glucose level on day 21. This was assumed 
that the dose 203 mg/kg BW gave the reducing blood 
glucose level faster than others. On this day, metformin 
and all three treated groups showed the reducing blood 
glucose level which were statistically significantly 
different to the control (Figure 4). 
One day after treatment (H8), standard group showed 
the highest reducing of blood glucose level compared to 
all other groups. On day 10 and 14, the highest percentage 
was shown by treated group with dose 90 mg/kg BW. 
While on day 21, the highest reducing of blood glucose 
level was shown by treated group on dose of 135 and 203 
mg/kg BW and have almost similar percentage. On day 
28, the highest percentage was shown by treated group 
on dose of 203 mg/kg BW. The percentage of reducing 
was dose dependent on this day. On day 1 after induction, 
treated group on dose 203 mg/kg BW showed the increase 
of blood glucose level compared to previous days. Single 
treatment of this dose did not show the decreasing of 
blood glucose level yet. The reducing activity increased 
after continuously treatment. At the end of treatment, on 
day 28, the highest reducing was given by treated group 
with dose 203 mg/kg BW. Percentage of reducing blood 
glucose level on day 28 for standard, treated group with 
dose 90, 135, and 203 mg/kg BW were 33.05, 38.82, 
41.79, and 44.42% (Figure 5). This showed that the dose 
203 mg/kg BW gave the optimal activity for reducing of 
blood glucose level. 
For diabetes patients, it is often accompanied with 
the increase of serum triglyceride and cholesterol levels. 
This is caused by the mechanism of insulin in inhibition of 
lipase activity. Lipase break the lipids so called lipolysis 
which convert triglyceride into glycerol and fatty acids. 
  2163
The fatty acids are re-synthesized into triglyceride. 
Alloxan cause the defect of β-pancreas leading to insulin 
deficiency. As the compensation, lipolysis process is not 
inhibited leading to the accumulation of fatty acids. This 
cause the increase of re-synthesis of triglyceride and 
other lipoprotein including cholesterol. The highest blood 
glucose level related to the increase the triglyceride 
level. Through the biochemical process, glucose is 
converted into acetyl-CoA, which is converted further 
into fatty acids. Fatty acids from lipogenesis as well as 
from the food intake will be converted into triglyceride 
with the esterification. 
Triglyceride (TG) and total cholesterol (CL) profile 
of mouse serum on day after induction with alloxan 
showed the increase of both for all groups. The 
increase of TG was ranging 143-185 mg/dL (Figure 
6), while the increase of CL was ranging 137-178 mg/
dL (Figure 7). According the European Atherosclerosis 
Society, hypercholesterolemia and hypertriglyceridemia 
were shown by plasma CL and TG level above >200 
mg/dL. The TG and CL of the animal model in this 
study were not classified as hypercholesterolemia and 
hypertriglyceridemia but have the risk of them. The TG 
and CL level showed in Figures 6 and 7 have almost 
similar profile, where the decrease of TG and CL level 
was shown by standard group which was statistically 
significant compare to the control (p<0.05). Treated groups 
on dose of 90 and 135 mg/kg BW suppressed the increase 
of TG and CL level, while treated group on dose of 203 
mg/kg BW did not show suppressed the decrease of TG 
and C level. The decrease activity on TG and CL was not 
shown by all three treated groups since there were not 
statistically different to standard group (p<0.05).    
Metformin has the mechanism to increase activity 
of insulin in liver, muscle, and fat. Insulin has a role in 
metabolism of glucose and lipid. Insulin suppress the 
production of liver glucose, breaking of glycogen. In fat 
tissue, glucose is converted into free fatty acids and stored 
in a form of triglyceride. Insulin protect the breaking of 
triglyceride into free fatty acids, the form that can be 
transported into other tissues to be used. Insulin decrease 
free fatty acids in circulation and stimulant the storage 
of triglyceride and cholesterol and adipocyte (Setter & 
Campbell 2000). Therefore, the metformin group showed 
the decrease of blood glucose level followed by the 
decrease of serum lipid level. 
P. niruri has been studied its antidiabetes, 
hipolipidemia, and antioxidant activities on diabetic rat. 
Hypogycaemic effect is probably due to the insulin activity 
or stimulant of insulin effect (Bavarva 2007). Zerumbone 
is a main component of Z. americans that has been 
studied its antioxidant and hepatoprotective activities 
(Fakurazi 2008). The antioxidant activity could protect 
β-pancreatic cell damage from a reactive- oxygen species 
(ROS) which is radical specied produced by alloxan.
The sample extracts only showed the suppression of 
the increase of TG and CL level on dose of 90 and 135 mg/
kg BW. They did not show the decrease of TG and CL level. 
This is probably caused by the effect on the inhibition of 
resistance of TG and CL and did not influence toward the 
storage of TG and CL into adipocyte tissues, so that the 
TG and CL level in plasma was not changed after treatment. 
FIGURE 1. TLC chromatogram of sample extract (1), 
Phyllanthus niruri extract (2), Zingiber americans extract 
(3), quercetrin (4) and quercetin (5), visualization with spray 
reagent H2SO4 10% in methanol (left), citroborate (right), 
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FIGURE 2. Blood glucose level profile using glucose 
tolerance method. Dose are in mg/kg BW, Individual 
values expressed as means ± standard deviation are 
averages of three independent experiments
FIGURE 3. Percentage of the reducing of blood glucose 
level profile using glucose tolerance method. T60-T0 = Day 
60 compare to day 0, T60-T90, T60-T120, and T60-T150 
= day 90, 120 and 150 respectively compare to day 60. 
Individual values expressed as means ± standard deviation 
are averages of three independent experiments
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FIGURE 4. Blood glucose level profile using alloxan induced 
method. Dose are in mg/kgBW, Individual values expressed as 




























Control Metformin Dose 90 Dose 135 Dose 203
FIGURE 5. Percentage of the reducing of blood glucose 
level profile using alloxan induced method. Day 10, 14, 21 
and 28 compare to day 7. Individual values expressed as 





FIGURE 7. Total cholesterol profile of all group using alloxan induced method. 
Individual values expressed as means ± standard deviation are averages of 
three independent experiments. 
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FIGURE 6. Triglyceride profile of all group using alloxan induced method. . 
Individual values expressed as means ± standard deviation are averages of three 
independent experiments.  
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Herbal product which produced from medicinal plants 
Phyllanthus niruri and Zingiber americana contains 
flavonoid, phenol, and tannin with concentration of 
0.15, 0.16, and 1.85%, respectively. The extract with 
all doses showed the reducing of blood glucose level of 
animal model. The optimum reducing of glucose blood 
level was given by the extract dose 203 mg/kg BW. The 
reducing cholesterol and triglyceride level were given 
by extract dose 90 and 135 mg/kg BW.
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